Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in Mice

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Sliva, Daniel ^a,b,c   Loganathan, Jagadish ^a   Jiang, Jiahua ^a   Jedinak, Andrej ^a   Lamb, John G ^d   Terry, Colin ^a   Baldridge, Lee Ann ^b   Adamec, Jiri ^e   Sandusky, George E ^b   Dudhgaonkar, Shailesh ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; CYTOCHROME P450 1A2; CYTOCHROME P450 3A1; CYTOCHROME P450 3A4; GANODERMA LUCIDUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER PREVENTION; CELL INFILTRATION; CELL PROLIFERATION; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE;

AMINOPYRIDINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CARCINOGENS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC NEOPLASMS; DEXTRAN SULFATE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMIDAZOLES; INFLAMMATION; MACROPHAGES; MICE; NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; REISHI;

BASIDIOMYCOTA; GANODERMA LUCIDUM; MUS;

EID: 84868107465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047873     Document Type: Article

References (51)

1. Sugimura T, (2000) Nutrition and dietary carcinogens. Carcinogenesis 21: 387-395.
2. Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, et al. (2005) Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 65: 8034-8041.
3. Rohrmann S, Hermann S, Linseisen J, (2009) Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study. Am J Clin Nutr 89: 1418-1424.
4. Hussain SP, Harris CC, (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121: 2373-2380.
5. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CBHW, (2002) Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenter- Suppl: 48-53.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR. 2007.
7. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY, (2002) Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97: 531-535.
8. Hara M, Hanaoka T, Kobayashi M, Otani T, Adachi HY, et al. (2003) Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 46: 138-147.
9. Zhang M, Huang J, Xie X, Holman CDAJ, (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124: 1404-1408.
10. Shin A, Kim J, Lim SY, Kim G, Sung MK, et al. (2010) Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer 62: 476-483.
11. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME, (2008) The immunobiology of mushrooms. Exp Biol Medicine 233: 259-276.
12. Mattila P, Suonpaa K, Piironen V, (2000) Functional properties of edible mushrooms. Nutrition 16: 694-696.
13. Sliva D, (2006) Ganoderma lucidum in cancer research. Leukemia Res 30: 767-768.
14. Kimura Y, Taniguchi M, Baba K, (2002) Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22: 3309-3318.
15. Weng CJ, Chau CF, Yen GC, Liao JW, Chen DH, et al. (2009) Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem 57: 5049-5057.
16. Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H, (2002) Prevention of development of N,N′-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med 9: 113-117.
17. Lu H, Uesaka T, Katoh O, Kyo E, Watanabe H, (2001) Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep 8: 1341-1345.
18. Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, et al. (2005) Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis 26: 229-238.
19. Tanaka T, (2009) Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinogenesis 8: 5.
20. Gupta AK, Schoen RE, (2009) Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Op Gastroenterol 25: 59-65.
21. Steffensen IL, Paulsen JE, Eide TJ, Alexander J, (1997) 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 18: 1049-1054.
22. Nishikawa A, Imazawa T, Kuroiwa Y, Kitamura Y, Kanki K, et al. (2005) Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol Sci 84: 243-248.
23. Kikuchi Y, Dinjens WN, Bosman FT, (1997) Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Arch 431: 111-117.
24. Nakanishi M, Tazawa H, Tsuchiya N, Sugimura T, Tanaka T, et al. (2007) Mouse strain differences in inflammatory responses of colonic mucosa induced by dextran sulfate sodium cause differential susceptibility to PhIP-induced large bowel carcinogenesis. Cancer Sci 98: 1157-1163.
25. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterol 98: 694-702.
26. Islam MS, Murata T, Fujisawa M, Nagasaka R, Ushio H, et al. (2008) Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol 154: 812-824.
27. Smina TP, Mathew J, Janardhanan KK, Devasagayam TP, (2011) Antioxidant activity and toxicity profile of total triterpenes isolated from Ganoderma lucidum (Fr.) P. Karst occurring in South India. Environ Toxicol Pharmacol 32: 438-446.
28. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, et al. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-674.
29. Shan L, He M, Yu M, Qiu C, Lee NH, et al. (2002) cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine and 7,12- dimethylbenz[a]anthracene. Carcinogenesis 23: 1561-1568.
30. Wang D, Dubois RN, (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29: 781-788.
31. Cheung C, Ma X, Krausz KW, Kimura S, Feigenbaum L, et al. (2005) Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol 18: 1471-1478.
32. Graham MJ, Lake BG, (2008) Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254: 184-191.
33. Kuhnel D, Taugner F, Scholtka B, Steinberg P, (2009) Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats. Arch Toxicol 83: 763-768.
34. Mabley JG, Pacher P, Liaudet L, Soriano FG, Haskó G, et al. (2003) Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 284: G138-144.
35. Ishikawa TO, Herschman HR, (2010) Tumor formation in a mouse model of colitis associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis 31: 729-736.
36. Ishikawa TO, Oshima M, Herschman HR, (2011) Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. Carcinogenesis 32: 417-426.
37. Balkwill F, Charles KA, Mantovani A, (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217.
38. Dudhgaonkar S, Thyagarajan A, Sliva D, (2009) Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol 9: 1272-1280.
39. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D, (2004) Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216.
40. Dutra RC, Claudino RF, Bento AF, Marcon R, Schmidt EC, et al. (2011) Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One 6: e27122.
41. Wang X, Zhao X, Li D, Lou YQ, Lin ZB, et al. (2007) Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharmacol Bull 30: 1702-1706.
42. Pascussi JM, Gerbal-Chaloin S, Duret C, Daujat-Chavanieu M, Vilarem MJ, et al. (2008) The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 48: 1-32.
43. Yang X, Guo M, Wan YJ, (2010) Deregulation of growth factor, circadian clock, and cell cycle signaling in regenerating hepatocyte RXRalpha-deficient mouse livers. Am J Pathol 176: 733-743.
44. Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, et al. (2004) Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127: 26-40.
45. Mori Y, Koide A, Tatematsu K, Sugie S, Mori H, (2005) Effects of alpha-naphthyl isothiocyanate and a heterocyclic amine, PhIP, on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mutagenesis 20: 15-22.
46. Hou XL, Takahashi K, Kinoshita N, Qiu F, Tanaka K, et al. (2007) Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 337: 169-177.
47. Adamec J, Jannash A, Dudhgaonkar S, Jedinak A, Sedlak M, et al. (2009) Development of a new method for improved identification and relative quantification of unknown metabolites in complex samples: Determination of a triterpenoid metabolic fingerprint for the in situ characterization of Ganoderma bioactive compounds. J Sep Sci 32: 4052-4058.
48. Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, et al. (2009) Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB- based model. Anticancer Res 29: 4995-4998.
49. Bobek P, Galbavy S, (2001) Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 58: 164-168.
50. Ward JM, (1974) Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 30: 505-513.
51. Nakagama H, Nakanishi M, Ochiai M, (2005) Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP. Cancer Sci 96: 627-636.